Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis.
D000208:Acute Disease; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001419:Bacteria / Q000254:growth & development; D001424:Bacterial Infections / Q000382:microbiology; D018988:Bacterial Translocation; D002766:Cholecystokinin / Q000494:pharmacology; D002908:Chronic Disease; D004751:Enteritis / Q000139:chemically induced / Q000150:complications* / Q000382:microbiology* / Q000473:pathology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005769:Gastrointestinal Motility; D007213:Indomethacin / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D007410:Intestinal Diseases / Q000097:blood / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D007958:Leukocyte Count; D008297:Male; D019335:Nitroarginine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D014409:Tumor Necrosis Factor-alpha; D019335:Nitroarginine; D002766:Cholecystokinin; D007213:Indomethacin